Assembly Biosciences, Inc. Share Price

Assembly Biosciences, Inc. Share Price

NASDAQ: ASMB | Micro Cap
$22.53
+$1.23 (5.80%) Last updated on 18 Nov, 2026 | 02:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Assembly Biosciences, Inc. Stock Performance

Open
$21.26
Prev. Close
$21.30
Circuit Range
N/A
Day Range
$21.26 - $22.58
Year Range
$19.30 - $39.22
Volume
21,072
Average Traded
$22.35

Assembly Biosciences, Inc. Share Price Today

As of 18 November 2026, Assembly Biosciences, Inc.'s share price is $22.53. The stock opened at $21.26, compared to its previous close of $21.30. During today's trading session, Assembly Biosciences, Inc.'s share price traded between $21.26 and $22.58, with an average price of $21.92. Over the past 52 weeks, the stock has recorded a high of $39.22 and a low of $19.30. In terms of performance, Assembly Biosciences, Inc.'s share price has declined by 18.52% over the last six months and is down 40.37% on a year-on-year basis.

Assembly Biosciences, Inc. Share Price Chart

Line chart of the Assembly Biosciences, Inc. price trend over the selected period. The price rose overall, ranging from 21.26 to 22.59, ending at 22.53.
$21.26$22.58
L
Show Current Price
H

Assembly Biosciences, Inc. Stock Fundamentals & Key Indicators

Market Cap
$252.58M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.54
Revenue (TTM)
$72.30B
Return On Equity (TTM)
-3.72%
Profit Margin
-8.46%
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-191.72%

Assembly Biosciences, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$42.47$8.21$13.37$2.96
Net Profit$22.09-$9.08-$3.86-$20.26
Net Profit Margin52.01%-110.60%-28.87%-684.46%
Income ChangeN/A-141.10%57.49%-424.87%

Assembly Biosciences, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$7.16$28.52$72.30
Net Profit-$93.09-$61.23-$40.18-$6.12
Net Profit MarginN/A-855.17%-140.88%-8.46%
Income ChangeN/A34.22%34.38%84.77%

About Assembly Biosciences, Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. The Company's pipeline includes multiple clinical-stage investigational therapies, including: (1) two long-acting helicase-primase inhibitors (HPI) for the treatment of recurrent genital herpes; (2) an orally bioavailable hepatitis delta virus entry inhibitor; and (3) a potent next-generation capsid assembly modulator designed to disrupt the replication cycle of hepatitis B virus (HBV) at several key points. The Company's pipeline also includes a novel, oral broad-spectrum non-nucleoside polymerase inhibitor (NNPI) for the treatment of transplant-related herpesviruses.

Assembly Biosciences, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$20.52
$22.52
+11.32%
Oct 2026
$23.63
$20.23
-14.02%
Sep 2026
$35.02
$23.53
-32.39%
Aug 2026
$25.40
$34.80
+38.81%
Jul 2026
$27.18
$25.07
-9.00%
Jun 2026
$28.25
$27.55
-0.36%
May 2026
$26.73
$27.65
+3.64%
Apr 2026
$29.68
$26.68
-3.89%
Mar 2026
$29.91
$27.76
-7.00%
Feb 2026
$25.86
$29.85
+15.21%
Jan 2026
$34.20
$25.91
-23.72%
Dec 2025
$35.12
$33.97
-10.10%

ASMB Share Price FAQs